
Mounjaro की कीमत में वृद्धि से यूके के मरीजों को भारी बिलों का सामना करना पड़ रहा है
द्वारा सहकर्मी समीक्षा की गई Dr Colin Tidy, MRCGPद्वारा लिखित Thomas Andrew Porteus, MBCSमूल रूप से प्रकाशित 14 Aug 2025
मरीज की संपादकीय दिशानिर्देशों
- डाउनलोडडाउनलोड
- साझा करें
- Language
- चर्चा
- ऑडियो संस्करण
- Google पर पसंदीदा स्रोतों में जोड़ें
If you buy the weight-loss medicine Mounjaro privately in the UK you may see a steep price increase from September. The change will not affect you if you get your medicine from the NHS.
Here we show what are the alternatives and what you need to think about if you change or stop taking medicines.
इस लेख में:
वीडियो चयन
नीचे पढ़ना जारी रखें
What is Mounjaro and who uses it?
Mounjaro is the brand name for tirzepatide, a medicine that mimics hormones in your body to help control blood sugar and reduce appetite. It’s given by weekly injection and is licensed for type 2 diabetes and for weight loss and weight management in adults aged 18 and over.
Mounjaro is authorised for adult patients with a BMI of 30 or more (obesity), as well as those with a BMI between 27-30 (overweight) who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems.
At the moment, more than 1.5 million people in the UK use weight-loss medicines. Mounjaro is the most popular. Around 9 out of 10 people getting it do so privately, often through online providers or high-street pharmacies.
What’s changing?
सामग्री पर वापस जाएंFrom September, the manufacturer Eli Lilly is putting up the price. The highest dose, which is one of the most commonly used, will increase from around £122 to £330 per month - a rise of around 170%. Lower doses will also cost more, but the increases will be smaller.
These changes only apply to people buying the drug privately and not those getting the medicine on the NHS. NHS prices are agreed in separate deals and will stay the same.
नीचे पढ़ना जारी रखें
Why is this happening?
सामग्री पर वापस जाएंEli Lilly says the current private price in the UK was always temporary. The company initially set it low to help people access the drug earlier. Now that more research is available, and the drug has been launched in more countries, they say the UK price needs to match what other countries pay.
The manufacturer also said the price change was partly influenced by the global debate around medicine costs. In the US, President Donald Trump has suggested linking medicine prices to what’s paid in other countries. Eli Lilly says it supports fair pricing, but does not think that approach works in practice.
What are the alternatives?
सामग्री पर वापस जाएंWegovy is a different injectable weight-loss medicine, made by Novo Nordisk. It works in a similar way and is also available on private prescription in the UK. Some people may find it easier to access or afford than Mounjaro, depending on the dose and provider.
Other options include tablets such as orlistat, as well as lifestyle support services offered by the NHS or local councils. Not all treatments work in the same way, and they’re not right for everyone, so it’s important to get proper advice.
नीचे पढ़ना जारी रखें
What should you do next?
सामग्री पर वापस जाएंIf you’re using Mounjaro and worried about the cost, speak to your doctor or pharmacist. They can help you review your treatment and talk through other options.
Do not stop your injections suddenly without getting medical advice. A sudden stop can cause your blood sugar or appetite to change quickly, which might affect your health.
You can also ask about getting treatment through the NHS. Weight-loss medicines are only offered on the NHS in certain situations, but your doctor can explain whether you might qualify.
NHS England has announced that some people will now be able to get the Mounjaro jab from their doctor or at a local clinic.
This applies to people who have:
A BMI of 40 or above - or 37.5 if you are from a minority ethnic group.
Four out of five of the following health conditions - type 2 diabetes, high blood pressure, heart disease, high cholesterol, and sleep apnoea.
Patient picks

स्वास्थ्य समाचार
Influencers are promoting dangerous peptides on social media – and regulators are struggling to keep up
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers – and regulators struggling to keep up. Across Instagram, TikTok or YouTube, unapproved and harmful peptide products are being promoted as shortcuts to fat loss, anti-ageing, health and recovery and muscle growth. Peptides actually occur naturally in our body. They regulate a variety of important functions, including metabolism, appetite, hormone production and tissue repair. Synthetic versions of peptides are also used in some medicines, which are legitimate and have been clinically proven. These include GLP-1s (which are used for weight loss and managing diabetes) and insulin. But a booming, parallel “grey market” now exists online for unapproved peptide compounds. These products are primarily being sold by so-called wellness brands and in influencer-led storefronts. Many of these products are marketed as cutting-edge solutions for optimising health and body enhancement. The problem is that many of these substances have not undergone full clinical safety evaluation and are not approved for human use. Many have also been found to be contaminated with other harmful ingredients. Unapproved injectable peptides therefore pose serious health risks. Some of the risks they may pose00092-0/abstract) include nausea, vomiting, abdominal pain, gastrointestinal issues, headaches and fatigue or weakness. Immune issues, as well as allergic reactions and infections have also been reported. Moreover, there’s a clear lack of rigorous human safety data. Yet these risks often aren’t disclosed by the people selling them.
by Luke Cox

स्वास्थ्य समाचार
Ebola outbreak declared a global health emergency - what you need to know
The World Health Organization (WHO) has declared the Ebola outbreak in the Democratic Republic of the Congo a “public health emergency of international concern”, with cases now confirmed in neighbouring Uganda. Here is what you need to know.
by Professor Alimuddin Zumla
नीचे पढ़ना जारी रखें
लेखक के बारे मेंपूरा जीवन परिचय देखें

Thomas Andrew Porteus, MBCS
HealthTech
MBCS
Thomas writes to inform, inspire, and equip practice leaders and health professionals navigating change, drawing on two decades of hands-on work across the UK health system.
समीक्षक के बारे मेंपूरा जीवन परिचय देखें

Dr Colin Tidy, MRCGP
सामान्य चिकित्सक, चिकित्सा लेखक
MBBS, MRCGP, MRCP (Paediatrics), DCH
डॉ. कॉलिन टिडी एक एनएचएस डॉक्टर हैं, जो ऑक्सफोर्डशायर में स्थित हैं।.
लेख का इतिहास
इस पृष्ठ की जानकारी योग्य चिकित्सकों द्वारा सहकर्मी समीक्षा की गई है।.
Next review due: 14 Aug 2025
14 Aug 2025 | मूल रूप से प्रकाशित
द्वारा लिखित:
Thomas Andrew Porteus, MBCSद्वारा सहकर्मी समीक्षा की गई
Dr Colin Tidy, MRCGP

पूछें, साझा करें, जुड़ें।.
चर्चाओं को ब्राउज़ करें, प्रश्न पूछें, और सैकड़ों स्वास्थ्य विषयों पर अनुभव साझा करें।.

अस्वस्थ महसूस कर रहे हैं?
अपने लक्षणों का ऑनलाइन मुफ्त में मूल्यांकन करें
पेशेंट न्यूज़लेटर के लिए साइन अप करें
आपकी साप्ताहिक खुराक स्पष्ट, विश्वसनीय स्वास्थ्य सलाह की - जो आपको सूचित, आत्मविश्वासी और नियंत्रण में महसूस करने में मदद करने के लिए लिखी गई है।.
सदस्यता लेने पर आप हमारी स्वीकार करते हैं गोपनीयता नीति. आप किसी भी समय सदस्यता समाप्त कर सकते हैं। हम कभी भी आपका डेटा नहीं बेचते।.